Dialogue Health Technologies Inc
TSX:CARE
Dialogue Health Technologies Inc
TSX:CARE
Price:
5.14
CAD
0.1%
Market Closed
Market Cap:
CA$346.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Dialogue Health Technologies Inc
TSX:CARE
|
CA |
|
S
|
STL Global Ltd
NSE:SGL
|
IN |
|
China National Chemical Engineering Co Ltd
SSE:601117
|
CN |
|
Aether Global Innovations Corp
OTC:AETHF
|
CA |
Income Statement
Earnings Waterfall
Dialogue Health Technologies Inc
Dialogue Health Technologies Inc
Income Statement
Dialogue Health Technologies Inc
Dialogue Health Technologies Inc
Currency: CAD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue |
36
N/A
|
59
+64%
|
76
+28%
|
85
+12%
|
65
-24%
|
73
+14%
|
80
+9%
|
86
+8%
|
87
+1%
|
91
+4%
|
93
+3%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(21)
|
(36)
|
(45)
|
(50)
|
(38)
|
(42)
|
(44)
|
(46)
|
(44)
|
(42)
|
(41)
|
|
| Gross Profit |
14
N/A
|
23
+62%
|
30
+30%
|
35
+16%
|
26
-24%
|
31
+18%
|
36
+15%
|
41
+14%
|
43
+6%
|
49
+12%
|
52
+8%
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(35)
|
(55)
|
(69)
|
(74)
|
(49)
|
(59)
|
(66)
|
(70)
|
(67)
|
(69)
|
(67)
|
|
| Selling, General & Administrative |
(28)
|
(46)
|
(58)
|
(62)
|
(38)
|
(49)
|
(55)
|
(58)
|
(53)
|
(56)
|
(52)
|
|
| Research & Development |
(5)
|
(7)
|
(10)
|
(11)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(12)
|
|
| Depreciation & Amortization |
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
(1)
|
(3)
|
(2)
|
(3)
|
|
| Operating Income |
(20)
N/A
|
(32)
-59%
|
(39)
-21%
|
(39)
-1%
|
(23)
+42%
|
(28)
-23%
|
(30)
-7%
|
(29)
+2%
|
(24)
+19%
|
(20)
+14%
|
(15)
+28%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
0
|
(225)
|
(225)
|
(225)
|
(225)
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(2)
|
(2)
|
(4)
|
|
| Total Other Income |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(20)
N/A
|
(258)
-1 161%
|
(265)
-3%
|
(265)
0%
|
(248)
+6%
|
(27)
+89%
|
(29)
-7%
|
(29)
0%
|
(25)
+15%
|
(20)
+18%
|
(17)
+18%
|
|
| Net Income | ||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
(1)
|
|
| Income from Continuing Operations |
(20)
|
(258)
|
(264)
|
(264)
|
(248)
|
(27)
|
(29)
|
(29)
|
(25)
|
(20)
|
(17)
|
|
| Net Income (Common) |
(20)
N/A
|
(258)
-1 174%
|
(264)
-3%
|
(264)
0%
|
(251)
+5%
|
(27)
+89%
|
(29)
-6%
|
(29)
+1%
|
(26)
+9%
|
(22)
+17%
|
(19)
+12%
|
|
| EPS (Diluted) |
-0.31
N/A
|
-3.96
-1 177%
|
-4.14
-5%
|
-4.02
+3%
|
-4.47
-11%
|
-0.42
+91%
|
-0.44
-5%
|
-0.43
+2%
|
-0.39
+9%
|
-0.3
+23%
|
-0.26
+13%
|
|
Switch to:
Switch to:
See Also
Discover More
